ATE403149T1 - Diagnostische tests auf periostinbasis - Google Patents

Diagnostische tests auf periostinbasis

Info

Publication number
ATE403149T1
ATE403149T1 AT02757081T AT02757081T ATE403149T1 AT E403149 T1 ATE403149 T1 AT E403149T1 AT 02757081 T AT02757081 T AT 02757081T AT 02757081 T AT02757081 T AT 02757081T AT E403149 T1 ATE403149 T1 AT E403149T1
Authority
AT
Austria
Prior art keywords
periostin
diagnostic tests
based diagnostic
human periostin
preeclempsia
Prior art date
Application number
AT02757081T
Other languages
English (en)
Inventor
Lan Bo Chen
Meiru Dai
Hidefumi Sasaki
Daniel Auclair
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of ATE403149T1 publication Critical patent/ATE403149T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT02757081T 2001-08-13 2002-08-13 Diagnostische tests auf periostinbasis ATE403149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31212301P 2001-08-13 2001-08-13

Publications (1)

Publication Number Publication Date
ATE403149T1 true ATE403149T1 (de) 2008-08-15

Family

ID=23209980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02757081T ATE403149T1 (de) 2001-08-13 2002-08-13 Diagnostische tests auf periostinbasis

Country Status (8)

Country Link
US (2) US7087727B2 (de)
EP (1) EP1442295B1 (de)
JP (1) JP2005500059A (de)
AT (1) ATE403149T1 (de)
AU (1) AU2002323120A1 (de)
CA (1) CA2457065A1 (de)
DE (1) DE60227974D1 (de)
WO (1) WO2003016471A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1524524A1 (de) * 1998-12-18 2005-04-20 Scios Inc. Methode zur Detektion und Verwendung von differentiel exprimiertem OSF-2 in der Diagnose von Herzhypertrophie
AU2002323120A1 (en) * 2001-08-13 2003-03-03 Dana-Farber Cancer Institute, Inc. Periostin-based diagnostic assays
US7601505B2 (en) 2003-05-29 2009-10-13 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
IL177006A0 (en) * 2005-08-02 2006-12-10 Veridex Llc Predicting bone relapse of breast cancer
DK1806359T3 (da) * 2005-09-05 2010-06-14 Immatics Biotechnologies Gmbh Tumorassocierede peptider, der bindes promiskuøst til Humant Leukocyt-Antigen (HLA) klasse II molekyler
US8017119B2 (en) 2005-12-28 2011-09-13 Daiichi Sankyo Company, Ltd. Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
EP1806587A1 (de) * 2006-01-07 2007-07-11 Université de Liège In-vitro-Verfahren zum Screening zugänglicher biologischer Marker in pathologischen Geweben
WO2007096142A2 (en) 2006-02-22 2007-08-30 Philogen Spa Vascular tumor markers
JP5238942B2 (ja) * 2007-06-27 2013-07-17 国立大学法人大阪大学 ペリオスチンのＥｘｏｎ−１７部位によりコードされるペプチドに対する抗体を含む癌治療剤
WO2009075883A2 (en) * 2007-12-12 2009-06-18 University Of Georgia Research Foundation, Inc. Glycoprotein cancer biomarker
US8420310B2 (en) 2008-06-05 2013-04-16 Saga University Method for detection of idiopathic interstitial pneumonia
JP5632994B2 (ja) * 2008-12-19 2014-12-03 国立大学法人佐賀大学 非特発性間質性肺炎の治療薬のスクリーニング方法
FR2946349B1 (fr) * 2009-06-03 2013-10-04 Synarc Sas Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine
JP5885243B2 (ja) * 2009-12-02 2016-03-15 国立大学法人佐賀大学 胆管細胞癌の検出方法および予防・治療剤のスクリーニング方法
JP5555940B2 (ja) * 2010-04-14 2014-07-23 国立大学法人佐賀大学 増殖糖尿病網膜症の検出方法および予防・治療剤のスクリーニング方法
JP2012058048A (ja) * 2010-09-08 2012-03-22 Shino Test Corp ペリオスチン測定の正確性の改善方法
CA2817380C (en) 2010-12-16 2019-06-04 Genentech, Inc. Diagnosis and treatments relating to th2 inhibition
WO2012156513A1 (en) 2011-05-18 2012-11-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for determining whether a subject is at risk of having or developing a chronic kidney disease
JP6183809B2 (ja) 2011-09-06 2017-08-23 株式会社シノテスト ペリオスチンの特定領域に結合する抗体及びこれを用いたペリオスチンの測定方法
US20140363832A1 (en) * 2011-09-15 2014-12-11 National University Corporation Nagoya University Molecular marker for the early detection of malignant pleural mesothelioma and the methods of its expression analysis using blood and pleural effusion samples
JP5871228B2 (ja) * 2011-10-31 2016-03-01 国立大学法人佐賀大学 慢性副鼻腔炎の検出方法
US9198900B2 (en) 2011-11-10 2015-12-01 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Treatment of peritoneal injury using JAK inhibitors
WO2014136910A1 (ja) 2013-03-08 2014-09-12 国立大学法人大阪大学 ペリオスチンのＥｘｏｎ－２１部位によりコードされるペプチドに対する抗体及び該抗体を含む炎症関連疾患の予防又は治療用医薬組成物
WO2014153442A2 (en) * 2013-03-21 2014-09-25 The General Hospital Corporation Methods and systems for treatment of ovarian cancer
TWI819228B (zh) * 2013-08-05 2023-10-21 德商伊瑪提克斯生物科技有限公司 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（八）
CN110041403B (zh) 2013-08-05 2023-03-10 伊玛提克斯生物技术有限公司 针对多种肿瘤例如包括nsclc在内的肺癌的新型免疫疗法
EP3359210B1 (de) * 2015-10-08 2021-04-14 Université de Genève Periostinfragmente und verwendung davon
KR101888193B1 (ko) * 2016-02-19 2018-08-13 이화여자대학교 산학협력단 유방암 전이 진단 지표로서의 혈중 페리오스틴
CN106520771B (zh) * 2016-12-20 2019-02-12 江苏省人民医院 一种长非编码rna及其在诊断/治疗子痫前期中的应用
CA3093422A1 (en) * 2018-03-19 2019-09-26 Bioventures, Llc Periostin antibodies and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05268982A (ja) * 1992-03-27 1993-10-19 Hoechst Japan Ltd 骨形成作用を有する新規な蛋白質およびその製造法
US5889159A (en) * 1993-10-29 1999-03-30 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies to tumor marker TC1 and methods for use of same
AU744087B2 (en) * 1997-05-29 2002-02-14 Board Of Regents, The University Of Texas System OSF2/CBFA1 compositions and methods of use
EP1140137A2 (de) 1998-12-18 2001-10-10 Scios Inc. Methode zur detektion und verwendung von in krankenheitzuständen differentiell exprimierte gene
WO2001057062A1 (en) 2000-02-03 2001-08-09 Gene Logic, Inc. Modulation of osf-2 in inflammatory and renal diseases
AU2002323120A1 (en) * 2001-08-13 2003-03-03 Dana-Farber Cancer Institute, Inc. Periostin-based diagnostic assays

Also Published As

Publication number Publication date
US20030073137A1 (en) 2003-04-17
EP1442295A4 (de) 2005-08-17
EP1442295A2 (de) 2004-08-04
US7087727B2 (en) 2006-08-08
CA2457065A1 (en) 2003-02-27
AU2002323120A1 (en) 2003-03-03
WO2003016471A2 (en) 2003-02-27
JP2005500059A (ja) 2005-01-06
US20060228763A1 (en) 2006-10-12
WO2003016471A3 (en) 2003-08-21
EP1442295B1 (de) 2008-07-30
DE60227974D1 (de) 2008-09-11

Similar Documents

Publication Publication Date Title
ATE403149T1 (de) Diagnostische tests auf periostinbasis
AR037223A1 (es) Anticuerpos bloqueadores de cripto, composiciones que los comprenden, y metodos que los utilizan
DE60335022D1 (de) Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel
CR8231A (es) Anticuerpos rg1 y uso de los mismos
EP2360169A3 (de) PSMA Antikörper
DK1587957T3 (da) Genekspressionsmarkør til prognose af brystkræft
DK2097453T3 (da) Monoklonale antistoffer mod humant Anti-Müllerian Hormon type II receptor (AMHR-II)
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
CY1112101T1 (el) Νευροτροφικοι παραγοντες
ATE414535T1 (de) Trägerproteine für impfstoffe
MXPA04006517A (es) Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores.
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
CR10212A (es) Modulacion de la formacion osea
ATE470672T1 (de) Verwendung von cupredoxin-proteine für krebstherapie
WO2002088750A3 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
EP1090294A4 (de) Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-gens und peptiden, die von ssx oder ny-eso-1 abgeleitet sind
IL151448A0 (en) Proteins
MXPA05007940A (es) Composiciones y metodos para el tratamiento del cancer usando igsf9 y liv-1.
GB0324656D0 (en) A protein involved in ovarian cancer
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE313551T1 (de) Isoliertes nukleinsäuremolekül, das die tumorabstossungs-antigenvorläufer mage- c1 und mage-c2 kodiert und seine verwendung
ATE328899T1 (de) Zellkernlokalisierendes protein für beta-catenin
DE60226956D1 (de) Verstärktes krebs-gen wip1
RU2005128402A (ru) Способ определения биологического возраста человека

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties